Skip to Main Content

Paper Details

Children's Oncology Group's 2023 blueprint for research: Developmental therapeutics.
Pediatr Blood Cancer
0
2023
cabozantinib, cancer, children, larotrectinib, pediatric, pediatric tumors, to, trametinib, tumors
Author NameAffiliation
Donald W ParsonsBaylor College of Medicine
Donald W ParsonsBaylor College of Medicine
  • 1 - 2

Datasets

Release 1.2